Literature DB >> 15087645

Rebound pulmonary hypertension and cardiogenic shock after withdrawal of inhaled prostacyclin.

John G Augoustides1, Kym Culp, Steven Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15087645     DOI: 10.1097/00000542-200404000-00040

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  5 in total

Review 1.  Pharmacologic management of perioperative pulmonary hypertension.

Authors:  Julie W Cheng; Adriano R Tonelli; Gosta Pettersson; Richard A Krasuski
Journal:  J Cardiovasc Pharmacol       Date:  2014-04       Impact factor: 3.105

Review 2.  [Valvular heart disease: anesthesia in non-cardiac surgery].

Authors:  H Mutlak; M Humpich; K Zacharowski; R Lehmann; D Meininger
Journal:  Anaesthesist       Date:  2011-09       Impact factor: 1.041

3.  Pause at Your Own Peril: A Case Series on Rebound Pulmonary Hypertension.

Authors:  Sindhubarathi Murali; Subrat Khanal; Sanchari Banerjee; Omari Christie; Kartik Ramakrishna
Journal:  Cureus       Date:  2022-05-31

4.  Management of acute subdural hematoma in a patient with portopulmonary hypertension on prostanoid therapy.

Authors:  Richard Rammo; Adam Robin; Jessin John; Aqueel Pabaney; Panayiotis Varelas; Max Kole
Journal:  Surg Neurol Int       Date:  2017-08-01

5.  Droplet Size and Distribution of Nebulized 3% Sodium Chloride, Albuterol, and Epoprostenol by Phase Doppler Particle Analyzer.

Authors:  Kelly McDermott; Jason G Oakley
Journal:  Curr Ther Res Clin Exp       Date:  2021-02-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.